Sensitization and kindling phenomena in mood, anxiety, and obsessive- compulsive disorders: The role of serotonergic mechanisms in illness progression

Biological Psychiatry

Volumn 44, Issue 3, 1998, Pages 193-206

  Post, Robert M ^a   Weiss, Susan R B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Affective disorders; Anticonvulsants; Kindling; Lithium; Sensitization; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; LITHIUM; PROTIRELIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANXIETY NEUROSIS; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; KINDLING; MOOD; NONHUMAN; OBSESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; REVIEW; SEIZURE; SENSITIZATION; SEROTONINERGIC SYSTEM;

AFFECT; ANIMALS; ANXIETY; AROUSAL; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; KINDLING, NEUROLOGIC; OBSESSIVE-COMPULSIVE DISORDER;

EID: 0032145217     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00144-9     Document Type: Review

References (132)

1. Altshuler L.L., Post R.M., Leverich G.S., Mikalauskas K., Rosoff A., Ackerman L. Antidepressant-induced mania and cycle acceleration A controversy revisited . Am J Psychiatry. 152:1995;1130-1138.
2. Angst J., Merikangas K., Scheidegger P., Wicki W. Recurrent brief depression A new subtype of affective disorder . J Affect Disord. 19:1990;87-98.
3. Antelman S.M. Stressor-induced sensitization to subsequent stress Implications for the development and treatment of clinical disorders . Kalivas P.W., Barnes C.D. Sensitization in the Nervous System. 1988;227-254 Telford Press, Caldwell, NJ.
4. Artigas F., Sarrias M.J., Martinez E., Gelpi E., Alvarez E., Udina C. Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium. Psychopharmacology (Berl). 99:1989;328-332.
5. Arvidsson U., Cullheim S., Ulfhake B., Luppi P.H., Kitahama K., Jouvet M., et al. Quantitative and qualitative aspects on the distribution of 5-HT and its coexistence with substance P and TRH in cat ventral medullary neurons. J Chem Neuroanat. 7:1994;3-12.
6. Banki C.M., Bissette G., Arato M., Nemeroff C.B. Elevation of immunoreactive CSF TRH in depressed patients. Am J Psychiatry. 145:1988;1526-1531.
7. Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder A comparison with rates in unipolar depression and in normal controls . Arch Gen Psychiatry. 44:1987;211-218.
8. Baxter L.R. Jr, Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
9. Belmaker R.H., Fleischmann A. Transcranial magnetic stimulation A potential new frontier in psychiatry . Biol Psychiatry. 38:1995;419-421.
10. Benkelfat C., Seletti B., Palmour R.M., Hillel J., Ellenbogen M., Young S.N. Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission. Arch Gen Psychiatry. 52:1995;154-156.
11. Ben-Menachem E., Persson L.I., Hedner T. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin. Epilepsy Res. 11:1992;45-49.
12. Biggs C.S., Pearce B.R., Fowler L.J., Whitton P.S. Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain An in vivo microdialysis study . J Neurochem. 59:1992;1702-1708.
13. Bremner J.D., Southwick S.M., Johnson D.R., Yehuda R., Charney D.S. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry. 150:1993;235-239.
14. Brown G.W., Bifulco A., Harris T., Bridge L. Life stress, chronic subclinical symptoms and vulnerability to clinical depression. J Affect Disord. 11:1986;1-19.
15. Bunney W.E. Jr, Garland-Bunney B.L. Mechanisms of action of lithium in affective illness basic and clinical implications . Meltzer H.Y. Psychopharmacology The Third Generation of Progress . 1987;553-565 Raven Press, New York.
16. Callahan A.M., Frye M.A., Marangell L.B., George M.S., Ketter T.A., L'Herrou T., et al. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone Confounding effects of tolerance and implications for therapeutics . Biol Psychiatry. 41:1997;264-272.
17. Camu W., Marlier L., Lerner-Natoli M., Rondouin G., Privat A. Transplantation of serotonergic neurons into the 5,7-DHT-lesioned rat olfactory bulb restores the parameters of kindling. Brain Res. 518:1990;23-30.
18. Clark M., Post R.M., Weiss S.R.B., Cain C.J., Nakajima T. Regional expression of c-fos mRNA in rat brain during the evolution of amygdala-kindled seizures. Mol Brain Res. 11:1991;55-64.
19. Coppen A., Prange A.J. Jr, Whybrow P.C., Noguera R. Abnormalities of indoleamines in affective disorders. Arch Gen Psychiatry. 26:1972;474-478.
20. Cowen P.J., McCance S.L., Cohen P.R., Julier D.L. Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression. Psychopharmacology (Berl). 99:1989;230-232.
21. Crunelli V., Bernasconi S., Samanin R. Evidence against serotonin involvement in the tonic component of electrically induced convulsions and in carbamazepine anticonvulsant activity. Psychopharmacology (Berl). 66:1979;79-85.
22. Cunningham K.A., Paris J.M., Goeders N.E. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse. 11:1992;112-123.
23. Cunningham K.A., Paris J.M., Goeders N.E. Serotonin neurotransmission in cocaine sensitization. Ann NY Acad Sci. 654:1992;117-127.
24. Dailey J.W., Yan Q.S., Adams-Curtis L.E., Ryu J.R., Ko K.H., Mishra P.K., et al. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci. 58:1996;259-266.
25. Dailey J.W., Reith M.E., Yan Q.S., Li M.Y., Jobe P.C. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats Dose response relationships . Neurosci Lett. 227:1997;13-16.
26. Davis J.M., Wang Z., Janicak P.G. A quantitative analysis of clinical drug trials for the treatment of affective disorders. Psychopharmacol Bull. 29:1993;175-181.
27. Delgado P.L., Gelenberg A.J., Moreno F., Laukes C., Strayer L. Tryptophan and 5-HT in psychiatric illness. Adv Exp Med Biol. 398:1996;73.
28. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression [see comments]. Arch Gen Psychiatry. 54:1997;597-606.
29. During M.J., Craig J.S., Hernandez T.D., Anderson G.M., Gallager D.W. Effect of amygdala kindling on the in vivo release of GABA and 5-HT in the dorsal raphe nucleus in freely moving rats. Brain Res. 584:1992;36-44.
30. Ellinwood E.H. Jr, Kilbey M.M. Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biol Psychiatry. 15:1980;749-757.
31. Elphick M., Anderson S.M., Hallis K.F., Grahame-Smith D.G. Effects of carbamazepine on 5-hydroxytryptamine function in rodents. Psychopharmacol (Berl). 100:1990;49-53.
32. Elphick M., Yang J.D., Cowen P.J. Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses. Arch Gen Psychiatry. 47:1990;135-140.
33. Farber N.B., Hanslick J., Kirby C., McWilliams L., Olney J.W. Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity. Neuropsychopharmacology. 18:1998;57-62.
34. Fitton A., Goa K.L. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Drugs. 50:1995;691-713.
35. Funk D., Post R.M., Pert A. Role of central dopaminergic and 5-hydroxytryptaminergic projections in the behavioral responses elicited by thyrotropin-releasing hormone in rats. Psychopharmacol (Berl). 133:1997;356-362.
36. Gaggi R., Dall' O.R., Santangelo M., Roncada P. Actions of nimodipine on the serotonergic systems of rat brain. Gen Pharmacol. 29:1997;415-419.
37. George M.S., Ketter T.A., Post R.M. Prefrontal cortex dysfunction in clinical depression. Depression. 2:1994;59-72.
38. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 6:1995;1853-1856.
39. George MS, Jones M, Post RM, Putnam F, Mikalauskas K, Leverich GS (in press): The longitudinal course of affective illness: A mathematical model involving chaos theoryza. Psychiatr Res.
40. Glue P., Nutt D.J. Lithium treatment effect on serotonin function. Arch Gen Psychiatry. 47:1990;289-290.
41. Goddard G.V., Douglas R.M. Does the engram of kindling model the engram of normal long term memory? Can J Neurol Sci. 2:1975;385-394.
42. Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 25:1969;295-330.
43. Green W.H., Campbell M., David R. Psychosocial dwarfism A critical review of the evidence . J Am Acad Child Psychiatry. 23:1984;39-48.
44. Greenberg B.D., George M.S., Martin J.D., Benjamin J., Schlaepfer T.E., Altemus M., et al. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder A preliminary study . Am J Psychiatry. 154:1997;867-869.
45. Grof P., Angst J., Haines T. The clinical course of depression Practical issues . Angst J. Classification and Prediction of Outcome of Depression (Symposia Medica Hoechst, vol 8). 1974;141-148 F.K. Schattauer Verlag, Stuttgart.
46. Insel T.R., Mueller E.A., Alterman I. Obsessive-compulsive disorder and serotonin Is there a connection? Biol Psychiatry. 20:1985;1174-1188.
47. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev. 16:1991;223-244.
48. Kempermann G., Kuhn H.G., Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature. 386:1997;493-495.
49. Kessing L.V., Andersen P.K., Mortensen P.B., Bolwig T.G. Recurrence in affective disorder. I. Case register study. Br J Psychiatry. 172:1998;23-28.
50. Ketter T.A., Andreason P.J., George M.S., Lee C., Gill D.S., Parekh P.I., et al. Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry. 53:1996;59-69.
51. Ketter TA, Kimbrell TA, George MS, Stein RM, Willis MW, Benson BE, et al (1996): Baseline hypermetabolism may predict carbamazepine response, and hypometabolism nimodipine response in mood disorders [abstract]. Abstracts of the 20th C.I.N.P. Congress (#O-5-6):10.
52. Kimbrell T.A., Dunn R.T., Wassermann E.M., George M.S., Danielson A.L., Benson B.E., et al. Regional decreases in glucose metabolism with 1 Hz prefrontal transcranial magnetic stimulation (TMS) A new technique for tracing functional networks in the human brain [abstract] . Soc Neurosci Abstr. 23:1997;1576.
53. King G.R., Xiong Z., Ellinwood E.H. Jr. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine. Psychopharmacology (Berl). 130:1997;159-165.
54. Korte M., Staiger V., Griesbeck O., Thoenen H., Bonhoeffer T. The involvement of brain-derived neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments. J Physiol Paris. 90:1996;157-164.
55. Kostowski W., Ptaznik A., Nazar M., Jessa M. Antagonism of behavioral effects of electroconvulsive shock but not those of desipramine by the selective 5-HT-3 receptor antagonist, ondansetron. Pol J Pharmacol. 47:1995;193-195.
56. Kraepelin E (1921): Manic-Depressive Insanity and Paranoia (translated by R.M. Barclay, edited by G.M. Robertson). Edinburgh: E.S. Livingstone.
57. Kramlinger K.G., Post R.M. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry. 168:1996;314-323.
58. Kubek M.J., Liang D., Nie Y., Domb A.J., Byrd K.E. Single implantation of polymeric-TRH microdisks suppresses kindled epileptogenesis in the rat [abstract]. Soc Neurosci Abstr. 22:1996;2109.
59. Lazarova M., Roussinov K., Yanev S., Petkov V., Stach R., Kacz D. Effect of chronic para-chlorophenylalanine treatment on convulsive-seizure reactions. Acta Biol Med Ger. 40:1981;309-316.
60. Leander J.D. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia. 33:1992;573-576.
61. Lerner-Natoli M. Serotonin and kindling development. Int J Neurosci. 36:1987;139-151.
62. Lima L., Trejo E., Urbina M. Serotonin turnover rate, [3H]paroxetine binding sites, and 5-HT1A receptors in the hippocampus of rats subchronically treated with clonazepam. Neuropharmacology. 34:1995;1327-1333.
63. Maes M., Calabrese J., Jayathilake K., Meltzer H.Y. Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania Evidence for increased central serotonergic neurotransmission . Psychiatry Res. 71:1997;67-76.
64. Mandell A.J., Knapp S., Ehlers C., Russo P.V. The stability of constrained randomness Lithium prophylaxis at several neurobiological levels . Post R.M., Ballenger J.C. Neurobiology of Mood Disorders. 1984;744-776 Williams & Wilkins, Baltimore.
65. Marangell L.B., George M.S., Callahan A.M., Ketter T.A., Pazzaglia P.J., L'Herrou T.A., et al. Effects of intrathecal protirelin (thyrotropin-releasing hormone) in refractory depressed patients. Arch Gen Psychiatry. 54:1997;214-222.
66. Marcoli M., Maura G., Tortarolo M., Raiteri M. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum Involvement of 5-hydroxytryptamine2C receptors . J Neurochem. 69:1997;427-430.
67. McCance S.L., Cohen P.R., Cowen P.J. Lithium increases 5-HT-mediated prolactin release. Psychopharmacology (Berl). 99:1989;276-281.
68. McCann U.D., Kimbrell T.A., Morgan C.M., Anderson T., Geraci M., Benson B.E., et al. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Arch Gen Psychiatry. 55:1998;276-279.
69. Meltzer H.Y. Serotonergic function in the affective disorders The effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol . Ann NY Acad Sci. 430:1984;115-137.
70. Montgomery S.A., Montgomery D., Baldwin D., Green M. The duration, nature and recurrence rate of brief depressions. Prog Neuropsychopharmacol Biol Psychiatry. 14:1990;729-735.
71. Parsons L.H., Justice J.B. Jr. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J Neurochem. 61:1993;1611-1619.
72. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;233-237.
73. Pasini A., Tortorella A., Gale K. Anticonvulsant effect of intranigral fluoxetine. Brain Res. 593:1992;287-290.
74. Pauk J., Kuhn C.M., Field T.M., Schanberg S.M. Positive effects of tactile versus kinesthetic or vestibular stimulation on neuroendocrine and ODC activity in maternally-derived rat pups. Life Sci. 39:1986;2081-2087.
75. Paykel E.S. Causal relationship between clinical depression and life events. Barrett J.E., Rose R.M., Klerman G.L. Stress and Mental Disorder. 1979;71-86 Raven Press, New York.
76. Pinel J.P.J. Effects of diazepam and diphenylhydantoin on elicited and spontaneous seizures in kindled rats A double dissociation . Pharmacol Biochem Behav. 18:1983;61-63.
77. Pinel J.P.J., Rovner L.I. Electrode placement and kindling-induced experimental epilepsy. Exp Neurol. 58:1978;335-346.
78. Pinel J.P.J., Rovner L.I. Experimental epileptogenesis Kindling-induced epilepsy in rats . Exp Neurol. 58:1978;190-202.
79. Plotsky P.M., Meaney M.J. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res Mol Brain Res. 18:1993;195-200.
80. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 149:1992;999-1010.
81. Post R.M., Weiss S.R.B. Endogenous biochemical abnormalities in affective illness Therapeutic vs. pathogenic . Biol Psychiatry. 32:1992;469-484.
82. Post R.M., Weiss S.R.B. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol Neurobiol. 13:1996;33-60.
83. Post R.M., Weiss S.R.B. Emergent properties of neural systems How focal molecular neurobiological alterations can affect behavior . Dev Psychopathol. 9:1997;907-929.
84. Post R.M., Kennedy C., Shinohara M., Squillace K., Miyaoka M., Suda S., et al. Metabolic and behavioral consequences of lidocaine-kindled seizures. Brain Res. 324:1984;295-303.
85. Post R.M., Weiss S.R.B., Pert A., Uhde T.W. Chronic cocaine administration Sensitization and kindling effects . Raskin A., Fisher S. Cocaine Clinical and Biobehavioral Aspects . 1987;109-173 Oxford University Press, New York.
86. Post R.M., Altshuler L.L., Ketter T.A., Denicoff K., Weiss S.R.B. Antiepileptic drugs in affective illness Clinical and theoretical implications . Smith D.B., Treiman D.M., Trimble M.R. Advances in Neurology, vol 55 Neurobehavioral Problems in Epilepsy . 1991;239-277 Raven Press, New York.
87. Post R.M., Weiss S.R.B., Pert A. Animal models of mania. Willner P., Scheel-Kruger J. The Mesolimbic Dopamine System From Motivation to Action . 1991;443-472 Wiley, Chichester, England.
88. Post R.M., Weiss S.R.B., Fontana D., Pert A. Conditioned sensitization to the psychomotor stimulant cocaine. Ann NY Acad Sci. 654:1992;386-399.
89. Post R.M., Weiss S.R.B., Chuang D., Ketter T.A. Mechanisms of action of carbamazepine in seizure and affective disorders. Joffe R.T., Calabrese J.R. Anticonvulsants in Mood Disorders. 1994;43-92 Marcel Dekker, New York.
90. Post R.M., Weiss S.R.B., Leverich G.S. Recurrent affective disorder Roots in developmental neurobiology and illness progression based on changes in gene expression . Dev Psychopathol. 6:1994;781-813.
91. Post R.M., Weiss S.R.B., Smith M. Sensitization and kindling Implications for the evolving neural substrate of PTSD . Friedman M.J., Charney D.S., Deutch A.Y. Neurobiology and Clinical Consequences of Stress From Normal Adaptation to PTSD . 1995;203-224 Lippincott-Raven, Philadelphia.
92. Post R.M., Ketter T.A., Denicoff K., Pazzaglia P.J., Leverich G.S., Marangell L.B., et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl). 128:1996;115-129.
93. Post R.M., Weiss S.R.B., Leverich G.S., George M.S., Frye M., Ketter T.A. Developmental psychobiology of cyclic affective illness Implications for early therapeutic intervention . Dev Psychopathol. 8:1996;273-305.
94. Post R.M., Weiss S.R.B., Smith M., Li H., McCann U. Kindling versus quenching Implications for the evolution and treatment of post-traumatic stress disorder . Ann NY Acad Sci. 821:1997;285-295.
95. Post R.M., Kimbrell T., Frye M., George M., McCann U., Little J., et al. Implications of kindling and quenching for the possible frequency dependence of rTMS. CNS Spectrums. 2:1997;54-60.
96. Powell G.F., Brasel J.A., Blizzard R.M. Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. I. Clinical evaluation of the syndrome. N Engl J Med. 276:1967;1271-1278.
97. Powell G.F., Brasel J.A., Raiti S., Blizzard R.M. Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. II. Endocrinologic evaluation of the syndrome. N Engl J Med. 276:1967;1279-1283.
98. Prange A.J. Jr, Lara P.P., Wilson I.C., Alltop L.B., Breese G.R. Effects of thyrotropin-releasing hormone in depression. Lancet. 2:1972;999-1002.
99. Pratt J.A., Jenner P., Marsden C.D. Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5HT in mouse brain. Neuropharmacology. 24:1985;59-68.
100. Prendiville S., Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia. 34:1993;381-384.
101. Price L.H., Charney D.S., Delgado P.L., Heninger G.R. Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Arch Gen Psychiatry. 46:1989;13-19.
102. Price L.H., Charney D.S., Delgado P.L., Heninger G.R. Lithium and serotonin function Implications for the serotonin hypothesis of depression . Psychopharmacol (Berl). 100:1990;3-12.
103. Rao M.L., Clarenbach P., Vahlensieck M., Kratzschmar S. Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm. 73:1988;129-134.
104. Rosen J.B., Cain C.J., Weiss S.R., Post R.M. Alterations in mRNA of enkephalin, dynorphin and thyrotropin releasing hormone during amygdala kindling An in situ hybridization study . Brain Res Mol Brain Res. 15:1992;247-255.
105. Rosen J.B., Abramowitz J., Post R.M. Co-localization of TRH mRNA and Fos-like immunoreactivity in limbic structures following amygdala kindling. Mol Cell Neurosci. 4:1993;335-342.
106. Roy-Byrne P.P., Geraci M., Uhde T.W. Life events and course of illness in patients with panic disorder. Am J Psychiatry. 143:1986;1033-1035.
107. Schanberg S.M., Field T., Kuhn C.M., Bartolome J. Touch A biological regulator of growth and behavior development in the neonate [abstract] . Biol Psychiatry. 33:1993;38A.
108. Sharp T., Bramwell S.R., Lambert P., Grahame-Smith D.G. Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro. Neuropharmacology. 30:1991;977-984.
109. Smith M., Weiss S.R.B., Abedin T., Post R.M., Gold P. Effects of amygdala-kindling and electroconvulsive seizures on the expression of corticotropin releasing hormone (CRH) mRNA in the rat brain. Mol Cell Neurosci. 2:1991;103-116.
110. Smith M.A., Makino S., Altemus M., Michelson D., Hong S.K., Kvetnansky R., et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci USA. 92:1995;8788-8792.
111. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotropic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15:1995;1768-1777.
112. Smith M.A., Weiss S.R., Berry R.L., Zhang L.X., Clark M., Massenburg G., et al. Amygdala-kindled seizures increase the expression of corticotropin-releasing factor (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus. Brain Res. 745:1997;248-256.
113. Sourkes T.L. Biochemistry of mental depression. Can Psychiatr Assoc J. 22:1977;467-481.
114. Southam E., Kirkby D., Pratt G.D., Higgins G., Hagan R.M. Lamotrigine inhibits 5-HT uptake in vitro and modulates the pCA-induced 5-HT syndrome [abstract]. Soc Neurosci Abstr. 23:1997;1661.
115. Swedo S.E., Leonard H.L., Kruesi M.J.P., Rettew D.C., Listwak S.J., Berrettini W., et al. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 49:1992;29-36.
116. Treiser S.L., Cascio C.S., O'Donohue T.L., Thoa N.B., Jacobowitz D.M., Kellar K.J. Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science. 213:1981;1529-1531.
117. van Praag H.M., de Haan S. Central serotonin metabolism and frequency of depression. Psychiatry Res. 1:1979;219-224.
118. Wada J.A., Sato M., Corcoran M.E. Persistent seizure susceptibility and recurrent spontaneous seizures in kindled cats. Epilepsia. 15:1974;465-478.
119. Wada Y., Hasegawa H., Nakamura M., Yamaguchi N. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Neurosci Lett. 138:1992;115-118.
120. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Role of serotonin subtype in seizures kindled from the feline hippocampus. Neurosci Lett. 141:1992;21-21.
121. Wada Y., Nakamura M., Hasegawa H., Yamaguchi N. Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci Lett. 159:1993;179-182.
122. Wada Y., Shiraishi J., Nakamura M., Koshino Y. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res. 747:1997;338-342.
123. Wada Y., Shiraishi J., Nakamura M., Koshino Y. Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy. Brain Res. 759:1997;313-316.
124. Wan R.-Q., Noguera E.C., Weiss S.R.B. Intrahippocampal injection of TRH produces anticonvulsant effects in amygdala kindled rats [abstract]. Soc Neurosci Abstr. 23:1997;2160.
125. Weiss S.R.B., Post R.M. Caveats in the use of the kindling model of affective disorders. J Toxicol Industr Health. 10:1995;421-447.
126. Weiss S.R.B., Post R.M., Pert A., Woodward R., Murman D. Context-dependent cocaine sensitization Differential effect of haloperidol on development versus expression . Pharmacol Biochem Behav. 34:1989;655-661.
127. Weiss S.R.B., Clark M., Rosen J.B., Smith M.A., Post R.M. Contingent tolerance to the anticonvulsant effects of carbamazepine Relationship to loss of endogenous adaptive mechanisms . Brain Res Rev. 20:1995;305-325.
128. Whitton P.S., Fowler L.J. The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur J Pharmacol. 200:1991;167-169.
129. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med. 3:1997;761-764.
130. Yan Q.S., Mishra P.K., Burger R.L., Bettendorf A.F., Jobe P.C., Dailey J.W. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J Pharmacol Exp Ther. 261:1992;652-659.
131. Yehuda R., Kahana B., Schmeidler J., Southwick S.M., Wilson S., Giller E.L. Impact of cumulative lifetime trauma and recent stress on current posttraumatic stress disorder symptoms in holocaust survivors. Am J Psychiatry. 152:1995;1815-1818.
132. Zhang L.X., Xing G.Q., Levine S., Post R.M., Smith M.A. Maternal deprivation induces neuronal death [abstract]. Soc Neurosci Abstr. 23:1997;1113.